Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr-abl.

Details

Language :

English

ISSN :

00207136

Volume :

110

Issue :

2

Database :

Complementary Index

Journal :

International Journal of Cancer

Publication Type :

Academic Journal

Accession number :

62200288

Full Text :

https://doi.org/10.1002/ijc.20115